Advertisement
Screener

Assembly Biosciences, Inc. (ASMB) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number

2.7 / 5 stars · 31/58 Roast Me

Assembly Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number

Assembly Biosciences, Inc. (ASMB) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 0 shares as of 2014-12-31, per its 10-K filed 2015-03-16.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2015-03-16

  • 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 0.00 shares.
  • 2014-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 0.00 shares.
  • 2014-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 151.24K shares.
  • 2013-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 75.00K shares; Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number as first filed 172.21K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, NumberShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number as first filed
2014-12-310.00 shares
10-K · filed 2015-03-16
2014-09-300.00 shares
10-Q · filed 2014-11-17
2014-06-30151.24K shares
10-Q · filed 2014-08-14
2013-12-3175.00K shares
10-K · filed 2015-03-16
172.21K shares
10-Q · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
Evolus, Inc. (EOLS)United States$0.519B-13.32
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53